{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:30:39Z","timestamp":1787499039818,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Brucellosis, a zoonotic disease caused by\n                      <jats:italic>Brucella<\/jats:italic>\n                      species, remains a major public health and economic challenge in regions dependent on livestock farming. In Iran, particularly in the western provinces, the disease imposes a heavy burden on healthcare systems and households through medical costs and productivity losses. This study quantified the economic burden of brucellosis in western Iran to inform policy and resource allocation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional cost-of-illness study was conducted among 427 brucellosis patients in Lorestan province\n                      <jats:bold>.<\/jats:bold>\n                      Data on direct medical costs (hospitalization, medications, diagnostics), direct non-medical costs (transportation, accommodation), and indirect costs (productivity losses) were collected using a bottom-up approach. All costs were expressed in 2024 USD, and sensitivity analyses were conducted at 0% and 5% discount rates. The catastrophic health expenditure (CHE) index was used to assess financial hardship.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean total cost per patient was 1,060 USD, with direct medical costs representing 73.6% of the total. Hospitalization was the largest component (38%), followed by surgical interventions (26%) and medications (13%). Indirect costs accounted for 18.9% of the total burden. The CHE index reached 66.3%, indicating severe financial strain for affected households. Sensitivity analyses showed notable variability in medical and non-medical cost estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Brucellosis imposes a substantial economic burden in western Iran, reflecting both healthcare and productivity losses. Effective control measures such as livestock vaccination, improved diagnosis, and expanded insurance coverage are essential to reduce financial hardship and support sustainable disease management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41182-025-00860-z","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:07:29Z","timestamp":1764252449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The economic burden of brucellosis in Western Iran"],"prefix":"10.1186","volume":"53","author":[{"given":"Meysam","family":"Behzadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banafsheh","family":"Darvishi Teli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Behzadifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"860_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12889-017-5016-y","volume":"18","author":"KA Franc","year":"2018","unstructured":"Franc KA, Krecek RC, H\u00e4sler BN, Arenas-Gamboa AM. Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action. BMC Public Health. 2018;18(1):125.","journal-title":"BMC Public Health"},{"issue":"6","key":"860_CR2","first-page":"349","volume":"21","author":"M Golshani","year":"2017","unstructured":"Golshani M, Buozari S. A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention. Iran Biomed J. 2017;21(6):349\u201359.","journal-title":"Iran Biomed J"},{"issue":"2","key":"860_CR3","doi-asserted-by":"publisher","first-page":"2295398","DOI":"10.1080\/07853890.2023.2295398","volume":"55","author":"KA Qureshi","year":"2023","unstructured":"Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, et al. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med. 2023;55(2):2295398.","journal-title":"Ann Med"},{"key":"860_CR4","doi-asserted-by":"publisher","first-page":"1168649","DOI":"10.3389\/fvets.2023.1168649","volume":"10","author":"A Kappes","year":"2023","unstructured":"Kappes A, Tozooneyi T, Shakil G, Railey AF, McIntyre KM, Mayberry DE, et al. Livestock health and disease economics: a scoping review of selected literature. Front Vet Sci. 2023;10:1168649.","journal-title":"Front Vet Sci"},{"issue":"14","key":"860_CR5","doi-asserted-by":"publisher","first-page":"e34324","DOI":"10.1016\/j.heliyon.2024.e34324","volume":"10","author":"M Dadar","year":"2024","unstructured":"Dadar M, Al-Khaza\u2019leh J, Fakhri Y, Akar K, Ali S, Shahali Y. Human brucellosis and associated risk factors in the Middle East region: a comprehensive systematic review, meta-analysis, and meta-regression. Heliyon. 2024;10(14):e34324.","journal-title":"Heliyon"},{"issue":"1","key":"860_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12879-024-09717-y","volume":"24","author":"CT Kulabako","year":"2024","unstructured":"Kulabako CT, Neema S, Ninsiima LR, Atuheire CG, Kal DO, Atekyereza P, et al. Understanding brucellosis: knowledge, perceptions, and self-reported prevalence among agro-pastoralists in Nakasongola, Uganda. BMC Infect Dis. 2024;24(1):797.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"860_CR7","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.14202\/vetworld.2022.2102-2110","volume":"15","author":"M Adabi","year":"2022","unstructured":"Adabi M, Khazaiee S, Sadeghi-Nasab A, Alamian S, Arabestani MR, Valiei Z, et al. Brucellosis in livestock: first study on seroepidemiology, risk factors, and preventive strategies to manage the disease in Famenin. Iran Vet World. 2022;15(8):2102\u201310.","journal-title":"Iran Vet World"},{"issue":"6","key":"860_CR8","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12571-021-01179-3","volume":"13","author":"JP Herrera","year":"2021","unstructured":"Herrera JP, Rabezara JY, Ravelomanantsoa NAF, Metz M, France C, Owens A, et al. Food insecurity related to agricultural practices and household characteristics in rural communities of northeast Madagascar. Food Secur. 2021;13(6):1393\u2013405.","journal-title":"Food Secur"},{"issue":"1","key":"860_CR9","doi-asserted-by":"publisher","first-page":"2322107","DOI":"10.1080\/20523211.2024.2322107","volume":"17","author":"MD Butt","year":"2024","unstructured":"Butt MD, Ong SC, Rafiq A, Kalam MN, Sajjad A, Abdullah M, et al. A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries. J Pharm Policy Pract. 2024;17(1):2322107.","journal-title":"J Pharm Policy Pract"},{"issue":"6","key":"860_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40273-023-01265-8","volume":"41","author":"B Wouterse","year":"2023","unstructured":"Wouterse B, van Baal P, Versteegh M, Brouwer W. The value of health in a cost-effectiveness analysis: theory versus practice. Pharmacoeconomics. 2023;41(6):607\u201317.","journal-title":"Pharmacoeconomics"},{"key":"860_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/7992287","volume":"2024","author":"HB He","year":"2024","unstructured":"He HB, Lu QS, Wang LL, Aishan M, Zhao JS, Tang XY, et al. The economic burden of brucellosis care in China: socioeconomic status inequality. J Trop Med. 2024;2024:7992287.","journal-title":"J Trop Med"},{"key":"860_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.prevetmed.2018.03.023","volume":"154","author":"BB Singh","year":"2018","unstructured":"Singh BB, Khatkar MS, Aulakh RSG, Ill JPS, Dhand NK. Estimation of the health and economic burden of human brucellosis in India. Prev Vet Med. 2018;154:148\u201355.","journal-title":"Prev Vet Med"},{"issue":"12","key":"860_CR13","doi-asserted-by":"publisher","first-page":"e0145086","DOI":"10.1371\/journal.pone.0145086","volume":"10","author":"O Vered","year":"2015","unstructured":"Vered O, Simon-Tuval T, Yagupsky P, Malul M, Cicurel A, Davidovitch N. The price of a neglected zoonosis: case-control study to estimate healthcare utilization costs of human brucellosis. PLoS ONE. 2015;10(12):e0145086.","journal-title":"PLoS ONE"},{"key":"860_CR14","first-page":"1","volume":"3","author":"U Anyanwu","year":"2024","unstructured":"Anyanwu U, Dimov A, Zinsstag J, Tediosi F, Markosyan T. Profitability and cost-effectiveness analysis of brucellosis control in Armenia: a one health approach. CABI One Health. 2024;3:1.","journal-title":"CABI One Health"},{"issue":"4","key":"860_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327\u201337.","journal-title":"Clin Mol Hepatol"},{"key":"860_CR16","unstructured":"World Bank. Official exchange rate (LCU per US$, period average) \u2013 Iran, Islamic Rep. 2025. Available at: https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF?locations=IR. Accessed 17 Oct 2025."},{"issue":"8","key":"860_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","volume":"29","author":"A Larg","year":"2011","unstructured":"Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29(8):653\u201371.","journal-title":"Pharmacoeconomics"},{"key":"860_CR18","doi-asserted-by":"publisher","first-page":"1478494","DOI":"10.3389\/fpubh.2024.1478494","volume":"12","author":"B Lyimo","year":"2024","unstructured":"Lyimo B, Hugho E, Mathew C, Mayenga C, Lukambagire AH, Lyimo S, et al. Seroprevalence and risk factors for brucellosis amongst livestock and humans in a multi-herd ranch system in Kagera, Tanzania. Front Public Health. 2024;12:1478494.","journal-title":"Front Public Health"},{"key":"860_CR19","doi-asserted-by":"publisher","first-page":"1136674","DOI":"10.3389\/fcimb.2023.1136674","volume":"13","author":"M Jin","year":"2023","unstructured":"Jin M, Fan Z, Gao R, Li X, Gao Z, Wang Z. Research progress on complications of Brucellosis. Front Cell Infect Microbiol. 2023;13:1136674.","journal-title":"Front Cell Infect Microbiol"},{"key":"860_CR20","doi-asserted-by":"publisher","first-page":"e01945","DOI":"10.1016\/j.idcr.2024.e01945","volume":"36","author":"WI Yahiaoui","year":"2024","unstructured":"Yahiaoui WI, Dahmani A. Brucellosis in hospitalized patients and their animals in the agro-pastoral region of Theniet El Had (Algeria) during ten years (2013-2023). IDCases. 2024;36:e01945.","journal-title":"IDCases"},{"issue":"8","key":"860_CR21","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/microorganisms11082070","volume":"11","author":"I Moriy\u00f3n","year":"2023","unstructured":"Moriy\u00f3n I, Blasco JM, Letesson JJ, De Massis F, Moreno E. Brucellosis and one health: inherited and future challenges. Microorganisms. 2023;11(8):2070.","journal-title":"Microorganisms"},{"issue":"3","key":"860_CR22","first-page":"465","volume":"94","author":"B Darvishi","year":"2021","unstructured":"Darvishi B, Behzadifar M, Ghanbari MK, Ehsanzadeh SJ, Bakhtiari A, Behzadifar M, et al. Financial protection indexes and the Iranian Health Transformation Plan: a systematic review. Yale J Biol Med. 2021;94(3):465\u201376.","journal-title":"Yale J Biol Med"},{"issue":"5","key":"860_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3961\/jpmph.22.195","volume":"55","author":"Y Kim","year":"2022","unstructured":"Kim Y, Kim Y, Lee HJ, Lee S, Park SY, Oh SH, et al. The primary process and key concepts of economic evaluation in healthcare. J Prev Med Public Health. 2022;55(5):415\u201323.","journal-title":"J Prev Med Public Health"},{"issue":"3","key":"860_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10198-020-01257-x","volume":"22","author":"L Hultkrantz","year":"2021","unstructured":"Hultkrantz L. Discounting in economic evaluation of healthcare interventions: what about the risk term? Eur J Health Econ. 2021;22(3):357\u201363.","journal-title":"Eur J Health Econ"},{"key":"860_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.prevetmed.2018.03.023","volume":"154","author":"BB Singh","year":"2018","unstructured":"Singh BB, Khatkar MS, Aulakh RS, Gill JPS, Dhand NK. Estimation of the health and economic burden of human brucellosis in India. Prev Vet Med. 2018;154:148\u201355.","journal-title":"Prev Vet Med"},{"key":"860_CR26","doi-asserted-by":"publisher","first-page":"105878","DOI":"10.1016\/j.prevetmed.2023.105878","volume":"213","author":"D Kiiza","year":"2023","unstructured":"Kiiza D, Denagamage T, Serra R, Maunsell F, Kiker G, Benavides B, et al. A systematic review of economic assessments for brucellosis control interventions in livestock populations. Prev Vet Med. 2023;213:105878.","journal-title":"Prev Vet Med"},{"issue":"2","key":"860_CR27","first-page":"E544","volume":"62","author":"M Behzadifar","year":"2021","unstructured":"Behzadifar M, Shahabi S, Zeinali M, Ghanbari MK, Martini M, Bragazzi NL. A policy analysis of agenda-setting of Brucellosis in Iran using a multiple-stream framework: health policy and historical implications. J Prev Med Hyg. 2021;62(2):E544\u201351.","journal-title":"J Prev Med Hyg"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00860-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T03:25:13Z","timestamp":1764300313000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00860-z","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Lorestan University of Medical Sciences approved this study (approval code no. IR.LUMS.REC.1403.336). All respondents were informed about the study and asked to provide informed consent before confirming their participation. Written informed consent was obtained from each study participant before initiating each key informant interview. For participants under the age of 16, informed consent was obtained from their parents or legal guardians. In the case of illiterate participants, informed consent was obtained from their legally authorized representatives (LAR) or close family members. Verbal informed consent was obtained from each participant (or their parents\/legal guardians\/LAR in the case of minors or illiterate individuals) before initiating the study. The study procedures and methods were conducted in accordance with the ethical principles and guidance in the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}